Floatz logo

Cyproheptadine

Pediatric Feeding Disorder, Chronic

University of MiamiSmall moleculePhase 4 / ApprovedActive
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pediatric Feeding Disorder, Chronic cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Cyproheptadine is also rated in:

avoidant/restrictive food intake disorderDormant
B
Indicative ·
59 / 100
View asset →
CachexiaDormant
CCC
Indicative ·
52 / 100
View asset →
childhood neoplasmDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →